To investigate the potential pathways involved in the mechanism of AXT in COPD, we performed network pharmacology analysis and found that the PI3K-AKT pathway was the most enriched pathway through multiple pathways and targets. The gene discussed is AKT1; the disease is chronic obstructive pulmonary disease.